Publications by authors named "Paula Keating"

Claim this Profile
A
Anti-HMGCR myopathy: estimated five-fold higher incidence in Polynesian compared with European populations in Aotearoa/New Zealand.
Ke Li Chow, Paula Elizabeth Keating, John Liston O'Donnell

Rheumatology (Oxford)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Homogenous Mobility Shift Assay for Infliximab and Adalimumab Anti-drug Antibody Detection in the Clinical Laboratory.
Paula Elizabeth Keating, Barry D Hock, Paul K L Chin, John Liston O'Donnell, Murray Lindsay Barclay

Ther Drug Monit· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand.
Ke Li Chow, Paula Elizabeth Keating, Kamal Solanki, Mark Sapsford, Karen Lindsay

Semin Arthritis Rheum· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Observational Study.
Lisa K Stamp, Paula Keating, Christopher Frampton, Murray L Barclay, Niamh Fanning

J Rheumatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic spectrum in a family with a novel p.I21S dominant-activating mutation.
Louisa Ashby, Lydia Chan, Christine Winterbourn, See-Tarn Woon, Paula Keating

Clin Transl Immunology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing.
Paula E Keating, Barry D Hock, Stewart M Smith, Paul K L Chin, John L O'Donnell

Intern Med J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtyping anti-infliximab antibodies by the homogenous mobility shift assay (HMSA): potential utility in a pharmacokinetic case study.
Ke Li Chow, Paula Elizabeth Keating, John Liston O'Donnell

Pathology· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HMGCR autoantibody testing: two tiers required.
Ke Li Chow, Paula Elizabeth Keating, Myfanwy Bailey Spellerberg, Ignatius Chua, John Liston O'Donnell

Pathology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A distinctive staining pattern with anti-3-hydroxy-3-methyl-glutaryl-coenzyme a reductase (HMGCR) antibodies on mouse kidney.
Paula Keating, Caroline Allan, John O'Donnell, Myfanwy Spellerberg, Mark van Voorthuizen

Pathology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the impact of an acute visiting scheme on emergency department attendances - a pre-post cohort design.
Axel Kaehne, Paula Keating

BMC Health Serv Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurate Measurement of Adalimumab Using Competitive Homogeneous Mobility Shift Assay.
Paula E Keating, John O'Donnell, Barry M Hock

Ther Drug Monit· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-pneumococcal antibody measurement: implications of discordance between second and third generation assays.
Caroline L M Allan, Paula E Keating, Stewart M Smith, Myfanwy B Spellerberg, John L O'Donnell

Pathology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of anti-natalizumab antibodies by homogeneous mobility shift assay.
Paula E Keating, Roderick Duncan, Myfanwy Spellerberg, John O'Donnell, Barry D Hock

Pathology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serum.
Barry D Hock, Stewart M Smith, Christopher J McEntyre, Judith L McKenzie, Christiaan Sies, Paula E Keating

J Immunol Methods· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.
Murray L Barclay, Shwan Karim, Esther T Johanna Helms, Paula E Keating, Barry Hock

Intern Med J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parent-Driven Campaign Videos: An Analysis of the Motivation and Affect of Videos Created by Parents of Children With Complex Healthcare Needs.
Bernie Carter, Lucy Bray, Paula Keating, Catherine Wilkinson

Compr Child Adolesc Nurs· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrimination of Anti-drug Antibodies With Neutralizing Capacity in Infliximab- and Adalimumab-Treated Patients: Comparison of the Homogeneous Mobility Shift Assay and the Affinity Capture and Elution Assay.
Barry D Hock, Judith L McKenzie, Liping Goddard, Stewart M Smith, Christopher J McEntyre, Paula E Keating

Ther Drug Monit· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: New immunoassays for anti-HMG-CoA reductase antibodies may lead to incorrect diagnosis in inflammatory myositis.
Paula Keating, Mark Van Voorthuizen, John Liu, Ignatius Chua, John O'Donnell

Pathology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HMGCR autoantibodies in self-limiting statin-induced myopathy.
Paula Keating, Joanna Young, Peter George, Chris Florkowski, Myfanwy Spellerberg

Int J Rheum Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an ELISA-Based Competitive Binding Assay for the Analysis of Drug Concentration and Antidrug Antibody Levels in Patients Receiving Adalimumab or Infliximab.
Barry D Hock, Lisa K Stamp, Matthew W Hayman, Paula E Keating, Esther T J Helms

Ther Drug Monit· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
Jacqueline M Orian, Paula Keating, Leana L Downs, Matthew W Hale, Xiangrui Jiang

Autoimmunity· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection from EAE by IL-4Ralpha(-/-) macrophages depends upon T regulatory cell involvement.
Paula Keating, David O'Sullivan, Joanna B Tierney, Diane Kenwright, Sara Miromoeini

Immunol Cell Biol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis